Overall response rate was 25.0 percent in phase 2 study involving 17 patients
Read More »Cabozantinib Promising for Advanced Adrenocortical Carcinoma
Promising efficacy seen with a manageable safety profile in phase 2 study involving 18 patients
Read More »New School Lunch Rules Target Added Sugars, Salt
By Robin Foster HealthDay ReporterTHURSDAY, April 25, 2024 (HealthDay News) — School lunches will soon contain less added sugar and salt under new nutrition standards announced by the U.S. Department of Agriculture on Wednesday.âWe all share the goal of helping children reach their full potential,â Agriculture Secretary Tom Vilsack said …
Read More »GLP1 Receptor Agonist Use Does Not Seem to Increase Risk for Thyroid Cancer
No increased risk for thyroid cancer seen with use of GLP1 receptor agonist versus DPP4 inhibitor use, SGLT2 inhibitor use
Read More »New Rules Mean 3.6 Million Americans Could Get Wegovy Via Medicare, Costing Billions
By Dennis Thompson HealthDay ReporterWEDNESDAY, April 24, 2024 (HealthDay News) — A budget-busting 3.6 million Medicare recipients could now be eligible for coverage of the weight-loss drug Wegovy, a new KFF analysis says.Thatâs because the U.S. Food and Drug Administration has approved the use of Wegovy (semaglutide) to reduce the …
Read More »ACP: Time-Restricted Eating May Not Aid Weight Loss, Glycemic Measures
Findings seen in trial where calories were held constant for both groups
Read More »ACP: Recommendations Developed for Newer Type 2 Diabetes Medications
Strong recommendation given for addition of SGLT-2 or GLP-1 agonist to metformin and lifestyle modifications
Read More »Risk Prediction Model Accurate for Chronic Kidney Disease
KDpredict more accurate than kidney failure risk equation for prediction of kidney failure risk
Read More »Big Health Care Disparities Persist Across the U.S., New Report Finds
By Dennis Thompson HealthDay ReporterTHURSDAY, April 18, 2024 (HealthDay News) — Deep-seated racial and ethnic disparities persist in health care across the United States, even in states considered the most progressive, a new report shows.For example, California received a score of 45 for the care its health system provides Hispanic …
Read More »Evidence Lacking for Gender Dysphoria Treatments for Teens
Two systematic reviews show inadequate evidence for use of treatment to suppress or lessen effect of puberty, hormone treatment
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.